TrialBMC cancer2016
Phase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial protocol.
Jessica A Martinez et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
21 papers cite it
this paperpooled ittrialcites it